DNA Repair Drugs Market Share

Statistics for the 2023 & 2024 DNA Repair Drugs market share, created by Mordor Intelligence™ Industry Reports. DNA Repair Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of DNA Repair Drugs Industry

The DNA repair drugs market is fragmented, with the presence of several global market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. These activities expand and increase the availability of products in various countries globally, which is likely to boost market growth. Some of the key players in the market are AstraZeneca PLC, Clovis Oncology, GSK PLC, Pfizer Inc., and Onxeo, among others.

DNA Repair Drugs Market Leaders

  1. AstraZeneca plc

  2. Clovis Oncology

  3. Pfizer Inc.

  4. Onxeo

  5. GSK plc

*Disclaimer: Major Players sorted in no particular order

DNA Repair Drugs Market Concentration

DNA Repair Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)